MICHAEL MOSLEY: Open Payments
NPI 1841970530 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 21 payments from 10 companies in 2025. Trend: 2023 $193 · 2024 $739 · 2025 $418
Food & beverage: $401Education: $17
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $80 |
| GENZYME CORPORATION | 3 | $69 |
| GlaxoSmithKline, LLC. | 4 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Grifols USA, LLC | 1 | $33 |
| Insmed, Inc. | 2 | $32 |
| Lilly USA, LLC | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $15 |
Products named: DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, Prolastin-C Liquid, ZEPBOUND, FASENRA, INSPIRE, OFEV.
Industry payments across PA — which companies pay providers there.
